Research Site

Tinley Park, Illinois 60487

1 studies enrolling now · 3 studies all time

What they study most

Advanced Solid Malignancies, Cardiovascular Disease, Relapsed or Refractory Multiple Myeloma

Studies at this site

• A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event — Recruiting now
• An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies. — Completed
• A Study of Carfilzomib Plus Dexamethasone in Adults With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers — Stopped early